Correlation Between Monte Rosa and Vigil Neuroscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Vigil Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Vigil Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Vigil Neuroscience, you can compare the effects of market volatilities on Monte Rosa and Vigil Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Vigil Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Vigil Neuroscience.

Diversification Opportunities for Monte Rosa and Vigil Neuroscience

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Monte and Vigil is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Vigil Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vigil Neuroscience and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Vigil Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vigil Neuroscience has no effect on the direction of Monte Rosa i.e., Monte Rosa and Vigil Neuroscience go up and down completely randomly.

Pair Corralation between Monte Rosa and Vigil Neuroscience

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 0.89 times more return on investment than Vigil Neuroscience. However, Monte Rosa Therapeutics is 1.13 times less risky than Vigil Neuroscience. It trades about -0.07 of its potential returns per unit of risk. Vigil Neuroscience is currently generating about -0.11 per unit of risk. If you would invest  890.00  in Monte Rosa Therapeutics on November 1, 2024 and sell it today you would lose (245.00) from holding Monte Rosa Therapeutics or give up 27.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Vigil Neuroscience

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Monte Rosa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Monte Rosa and Vigil Neuroscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Vigil Neuroscience

The main advantage of trading using opposite Monte Rosa and Vigil Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Vigil Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will offset losses from the drop in Vigil Neuroscience's long position.
The idea behind Monte Rosa Therapeutics and Vigil Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume